0,9000
13-февраля-25 14:09:01
15 мин. задержка
Акции
+0,0101
+1,13%
Сегодняшний диапазон
0,8700 - 0,9025
ISIN
N/A
Источник
NASDAQ
IMUNON Announces First Patient enrolled in Phase 1/2 Clinical Trial of IMNN-001 in Combination with bevacizumab in Advanced Ovarian Cancer
18 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
06 окт 2023 08:30:00 Источник Nasdaq GlobeNewswire